Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

View All Documentation

B4184

Sigma-Aldrich

Brij® L23 solution

30 % (w/v) in H2O

Synonyme(s) :

C12E23

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Numéro CAS:
9002-92-0
Numéro MDL:
MFCD00080891
Code UNSPSC :
12161900
ID de substance PubChem :
24891758
Nomenclature NACRES :
NA.25

Source biologique

synthetic

Niveau de qualité

200

Description

non-ionic

Forme

liquid

Poids mol.

~1198.0 g/mol

Concentration

30 % (w/v) in H2O

Nombre d'agrégation

40

CMC

91 μM

Température de transition

cloud point ≥100 °C

Solubilité

water: soluble

Densité

1.024 g/mL

HLB

16.9

Chaîne SMILES 

CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO

InChI

1S/C58H118O24/c1-2-3-4-5-6-7-8-9-10-11-13-60-15-17-62-19-21-64-23-25-66-27-29-68-31-33-70-35-37-72-39-41-74-43-45-76-47-49-78-51-53-80-55-57-82-58-56-81-54-52-79-50-48-77-46-44-75-42-40-73-38-36-71-34-32-69-30-28-67-26-24-65-22-20-63-18-16-61-14-12-59/h59H,2-58H2,1H3

Clé InChI

IEQAICDLOKRSRL-UHFFFAOYSA-N

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Catégories apparentées

Description générale

Brij® L23, also known as Polyoxyethylene (23) lauryl ether, is an ethoxylated fatty alcohol derived from lauryl alcohol. It serves as a valuable non-ionic detergent widely utilized in biochemical studies. This versatile compound is particularly well-suited for protein solubilization and membrane protein isolation, making it a key component in various biochemical assays. Brij® L23′s non-ionic nature and unique properties also position it as an essential detergent for protein extraction and cell permeabilization, facilitating a broad spectrum of research in the same. Further, its use is instrumental in preserving the structural integrity and functionality of proteins, contributing significantly to studies involving proteins and their interactions in the area of biochemical research.

Application

Brij® L23 solution has been used:
  • as a supplement of De Man, Rogosa, Sharpe (MRS) broth for monitoring bacteriocin production by lactic acid bacteria(66)
  • as a component of developing buffer for the incubation of zymogram gel for metalloproteinase quantification(67)
  • as a component of activation buffer for recombinant human hepsin(68)

Actions biochimiques/physiologiques

Brij® L23 solution is a surfactant and is used in the nanoparticle preparation by microemulsion method.

Caractéristiques et avantages

High-purity product ideal for biochemical research applications

Conditionnement

Some bottles may appear indented due to the packaging process. This does not affect product integrity or quality.

Notes préparatoires

In the event that material is in the gel phase at room temperature, the customer should heat the material to a temperature range of greater than 35°C and less than 60°C, and stir the solution for approximately 15 minutes before use.

Autres remarques

For additional information on our range of Biochemicals, please complete this form.

Informations légales

Brij is a registered trademark of Croda International PLC

Produit comparable

Réf. du produit
Description
Tarif

Pictogrammes

Exclamation markEnvironment
GHS07,GHS09

Mention d'avertissement

Warning

Mentions de danger

H315,H319,H411

Classification des risques

Aquatic Chronic 2 - Eye Irrit. 2 - Skin Irrit. 2

Code de la classe de stockage

10 - Combustible liquids

Classe de danger pour l'eau (WGK)

WGK 2

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable

Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number
0000394406
0000398865
0000394421
0000394580
0000394579

Vous ne trouvez pas la bonne version ?

Si vous avez besoin d'une version particulière, vous pouvez rechercher un certificat spécifique par le numéro de lot.

Rechercher un(e) COA

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Les clients ont également consulté

Slide 1 of 4

1 of 4

Brij® L4 average Mn ~362

Sigma-Aldrich

235989

Brij® L4

Hemoglobin human lyophilized powder

Sigma-Aldrich

H7379

Hemoglobin human

Microplaque Corning® 96 puits pour tests EIA/RIA 96 well plate, non-treated (medium bind), polystyrene, flat bottom, clear, non-sterile, 100/cs

CLS9017

Microplaque Corning® 96 puits pour tests EIA/RIA

Bobine de tube pour réacteur L × I.D. 5 m × 0.5 mm, volume 1.0 mL

57405

Bobine de tube pour réacteur

Reverse microemulsion synthesis of CeO2 nanopowder using polyoxyethylene (23) lauryl ether as a surfactant
Pournajaf R, et al.
Ceramics International, 40(6), 8687-8692 (2014)
Guillaume Morin et al.
Nutrients, 11(9) (2019-09-06)
Peroxides contaminating parenteral nutrition (PN) limit the use of methionine as a precursor of cysteine. Thus, PN causes a cysteine deficiency, characterized by low levels of glutathione, the main molecule used in peroxide detoxification, and limited growth in individuals receiving
Otte Brosjö et al.
Acta orthopaedica, 84(5), 502-505 (2013-11-01)
Recent data suggest that percutaneous sclerotherapy is a safe alternative to surgery for treatment of aneurysmal bone cysts (ABCs). We present our experience of this method. We retrospectively analyzed data from 38 consecutive patients treated with repeated injections of polidocanol.
Jun Koizumi et al.
AJR. American journal of roentgenology, 199(1), 200-207 (2012-06-27)
Balloon-occluded retrograde transvenous obliteration has been traditionally based on liquid sclerotherapy. However, overdose and systemic spillage of liquid sclerosant can cause severe complications, such as hemolysis, which lead to hemoglobinuria, allergy, acute respiratory distress syndrome, and other disorders. The purpose
Jacomina W van den Esschert et al.
Annals of surgery, 255(2), 311-318 (2012-01-14)
To compare the safety and hypertrophy response after portal vein embolization (PVE) using 2 absorbable and 3 permanent embolization materials. Portal vein embolization is used to increase future remnant liver volume preoperatively. Application of temporary, absorbable embolization materials could be
Afficher tous les articles scientifiques apparentés

Articles

Enzymatic Assay of Cathepsin B

Cathepsin B is a lysosomal cysteine proteinase with broad specificity. This protocol uses Nα–CBZ–Arg–Arg–7–amido–4–methylcoumarin as the substrate for fluorometric detection of Cathepsin B activity.

Enzymatic Assay of Cathepsin B

Cathepsin B is a lysosomal cysteine proteinase with broad specificity. This protocol uses Nα–CBZ–Arg–Arg–7–amido–4–methylcoumarin as the substrate for fluorometric detection of Cathepsin B activity.

Enzymatic Assay of Cathepsin B

Cathepsin B is a lysosomal cysteine proteinase with broad specificity. This protocol uses Nα–CBZ–Arg–Arg–7–amido–4–methylcoumarin as the substrate for fluorometric detection of Cathepsin B activity.

Enzymatic Assay of Cathepsin B

Cathepsin B is a lysosomal cysteine proteinase with broad specificity. This protocol uses Nα–CBZ–Arg–Arg–7–amido–4–methylcoumarin as the substrate for fluorometric detection of Cathepsin B activity.

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique